These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6427791)

  • 1. Inhibition of thromboxane synthetase by OKY-1581 stimulates the formation of PGE2, PGF2 alpha, PGD2 and 6-keto-PGF1 alpha in human platelets.
    Uotila P; Matintalo M
    Prostaglandins Leukot Med; 1984 Apr; 14(1):41-6. PubMed ID: 6427791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of aspirin and OKY-1581 on the metabolism of exogenous arachidonic acid in rat alveolar macrophages.
    Punnonen K; Uotila P; Mäntylä E
    Res Commun Chem Pathol Pharmacol; 1984 Jun; 44(3):367-74. PubMed ID: 6431566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological studies on the TXA2 synthetase inhibitor (E)-3-[p-(1H-imidazol-1-ylmethyl)phenyl]-2-propenoic acid (OKY-046).
    Hiraku S; Taniguchi K; Wakitani K; Omawari N; Kira H; Miyamoto T; Okegawa T; Kawasaki A; Ujiie A
    Jpn J Pharmacol; 1986 Jul; 41(3):393-401. PubMed ID: 3093741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of a thromboxane synthetase inhibitor, OKY-046, on urinary excretion of immunoreactive thromboxane B2 and 6-keto-prostaglandin F1 alpha in patients with ischemic cerebrovascular disease.
    Uyama O; Nagatsuka K; Nakabayashi S; Isaka Y; Yoneda S; Kimura K; Abe H
    Stroke; 1985; 16(2):241-4. PubMed ID: 3883580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective actions of a new thromboxane synthetase inhibitor in arachidonate induced sudden death.
    Edmonds LC; Lefer AM
    Life Sci; 1984 Oct; 35(17):1763-8. PubMed ID: 6434893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relation between thromboxane and prostaglandin synthesis in human decidua tissue: a comparison of eicosanoid synthesis in minced tissue with that in a cell-free preparation.
    Asbóth G; Gimes G; Hertelendy F; Tóth M
    Biochim Biophys Acta; 1989 Mar; 1002(1):101-8. PubMed ID: 2493805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin and thromboxane synthesis by M5076 ovarian reticulosarcoma during growth: effects of a thromboxane synthetase inhibitor.
    Chiabrando C; Broggini M; Castelli MG; Cozzi E; Castagnoli MN; Donelli MG; Garattini S; Giavazzi R; Fanelli R
    Cancer Res; 1987 Feb; 47(4):988-91. PubMed ID: 3100032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arachidonic acid induced platelet aggregation and thromboxane formation is inhibited by OKY-1581.
    Uotila P; Matintalo M; Dahl ML
    Prostaglandins Leukot Med; 1983 Nov; 12(3):299-303. PubMed ID: 6419237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of thromboxane A2 synthetase inhibition, singly and combined with thromboxane A2/prostaglandin endoperoxide receptor antagonism, on inositol phospholipid turnover and on 5-HT release by washed human platelets.
    de Chaffoy de Courcelles D; De Clerck F
    Eur J Pharmacol; 1990 Mar; 188(2-3):161-9. PubMed ID: 2318257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biosynthesis of lipoxygenase and cyclo-oxygenase products from [14C]-arachidonic acid by human colonic mucosa.
    Boughton-Smith NK; Hawkey CJ; Whittle BJ
    Gut; 1983 Dec; 24(12):1176-82. PubMed ID: 6416934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. R 68 070: thromboxane A2 synthetase inhibition and thromboxane A2/prostaglandin endoperoxide receptor blockade combined in one molecule--I. Biochemical profile in vitro.
    De Clerck F; Beetens J; de Chaffoy de Courcelles D; Freyne E; Janssen PA
    Thromb Haemost; 1989 Feb; 61(1):35-42. PubMed ID: 2546278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of OKY-046, a thromboxane A2 synthetase inhibitor, on arachidonate-induced platelet aggregation: possible role of "prostaglandin H2 steal" mechanism.
    Kuzuya T; Hoshida S; Yamagishi M; Ohmori M; Inoue M; Kamada T; Tada M
    Jpn Circ J; 1986 Nov; 50(11):1071-8. PubMed ID: 3102802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of OKY 1581 on bronchoconstrictor responses to arachidonic acid and PGH2.
    Tilden SJ; Underwood DC; Cowen KH; Wegmann MJ; Graybar GB; Hyman AL; McNamara DB; Kadowitz PJ
    J Appl Physiol (1985); 1987 May; 62(5):2066-74. PubMed ID: 2954941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of endotoxin-induced pulmonary hypertension in primates by the use of a selective thromboxane synthetase inhibitor, OKY 1581.
    Casey LC; Fletcher JR; Zmudka MI; Ramwell PW
    J Pharmacol Exp Ther; 1982 Aug; 222(2):441-6. PubMed ID: 6896528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. U-60,257 has no effect on the metabolism of arachidonic acid in nonstimulated human polymorphonuclear leukocytes.
    Dahl ML; Puustinen T; Uotila P
    Res Commun Chem Pathol Pharmacol; 1984 Jun; 44(3):355-65. PubMed ID: 6431565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of thromboxane synthetase inhibition on arachidonate metabolism and platelet behaviour.
    Parry MJ
    Br J Clin Pharmacol; 1983; 15 Suppl 1(Suppl 1):23S-29S. PubMed ID: 6401997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological studies on OKY-1581: a selective thromboxane synthetase inhibitor.
    Hiraku S; Wakitani K; Katsube N; Kawasaki A; Tsuboshima M; Naito J; Ujiie A; Komatsu H; Iizuka K
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():241-4. PubMed ID: 6221530
    [No Abstract]   [Full Text] [Related]  

  • 18. [Beneficial effect of a selective TXA2 synthetase inhibitor, OKY-046, both on thromboxane B2 production and vascular damage after spinal cord injury in rat spinal cord].
    Morimoto K; Ikata T; Tounai T
    Nihon Seikeigeka Gakkai Zasshi; 1990 Jan; 64(1):82-8. PubMed ID: 2319197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous infusion of a selective inhibitor of thromboxane A2 synthetase in man: influence on thromboxane B2 and 6-keto-prostaglandin F1 alpha levels and platelet aggregation.
    Yui Y; Hattori R; Takatsu Y; Nakajima H; Wakabayashi A; Kawai C; Kayama N; Hiraku S; Inagawa T; Tsubojima M
    Circulation; 1984 Oct; 70(4):599-605. PubMed ID: 6434196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic inhibition of thromboxane synthetase and platelet aggregation: modulatory role of cyclooxygenase products.
    Bertelé V; Falanga A; Tomasiak M; Chiabrando C; Cerletti C; de Gaetano G
    Blood; 1984 Jun; 63(6):1460-6. PubMed ID: 6426554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.